Katia Catherine Karalis serves as the Executive Director at Regeneron Pharmaceuticals, Inc., where she plays a pivotal role in advancing the company's mission to transform the lives of patients through innovative drug development. With her extensive background as a physician scientist trained in Clinical Molecular...
Katia Catherine Karalis serves as the Executive Director at Regeneron Pharmaceuticals, Inc., where she plays a pivotal role in advancing the company's mission to transform the lives of patients through innovative drug development. With her extensive background as a physician scientist trained in Clinical Molecular Genetics, Katia has established herself as a leader in the field of translational medicine. Her current focus revolves around the development of in vitro models for human genetic diseases, which are critical for understanding the mechanisms of action of human genetic variants. This work is particularly significant in areas such as inflammation, neuroinflammation, metabolism, and cancer, where she leverages her expertise to bridge the gap between laboratory research and clinical application.
Katia's involvement in key projects at Regeneron includes the integration of multidisciplinary technologies to create robust human disease models that facilitate drug discovery pipelines. Her collaborative efforts with the RGC and R&D leadership teams underscore her commitment to fostering innovation within the biopharma sector. By utilizing her skills in data analysis, pharmacology, and molecular & cellular biology, she is able to drive impactful research that not only meets regulatory standards but also addresses the needs of the global scientific community.
In addition to her technical acumen, Katia is dedicated to community outreach and cultural awareness, recognizing the importance of diverse perspectives in scientific research. Her comprehensive approach to drug development, combined with her passion for translational research, positions her as a world expert in her field, making significant contributions to the future of medicine and patient care.